EMA starts review of Ixchiq (live attenuated chikungunya vaccine)
Submitted by Anonymous (not verified) on 7 May 2025 - 13:00
EMA starts review of Ixchiq (live attenuated chikungunya vaccine)
Human medicines European public assessment report (EPAR): Evenity, romosozumab, Date of authorisation: 09/12/2019, Revision: 8, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2025 - 12:58
Human medicines European public assessment report (EPAR): Evenity, romosozumab, Date of authorisation: 09/12/2019, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Vectibix, panitumumab, Date of authorisation: 03/12/2007, Revision: 35, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2025 - 12:52
Human medicines European public assessment report (EPAR): Vectibix, panitumumab, Date of authorisation: 03/12/2007, Revision: 35, Status: Authorised
Human medicines European public assessment report (EPAR): Daurismo, glasdegib, Date of authorisation: 26/06/2020, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2025 - 12:39
Human medicines European public assessment report (EPAR): Daurismo, glasdegib, Date of authorisation: 26/06/2020, Revision: 6, Status: Authorised
EMA closed on 9 May
Submitted by Anonymous (not verified) on 7 May 2025 - 12:00
EMA closed on 9 May
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 21, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2025 - 11:22
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 21, Status: Authorised
10th EFIM Day
Submitted by Aneta on 7 May 2025 - 11:13
It is our great pleasure and honour to announce that the 10th EFIM Day will take place in Brussels on Friday 17 October .
We would like to extent an invitation to the Presidents, the Board Members and the Young Internists of EFIM National Societies to join EFIM in discussing different Internal Medicine’s topics on a European level including EFIM new projects and current activities.
The meeting will include presentations on upcoming projects and activities of EFIM including guest speakers from the EU community, as well as presentations from EFIM National Societies.
Agenda - EMA’s 30th anniversary scientific conference
Submitted by Anonymous (not verified) on 7 May 2025 - 10:12
Agenda - EMA’s 30th anniversary scientific conference
Human medicines European public assessment report (EPAR): Urorec, silodosin, Date of authorisation: 29/01/2010, Revision: 20, Status: Authorised
Submitted by Anonymous (not verified) on 7 May 2025 - 8:45
Human medicines European public assessment report (EPAR): Urorec, silodosin, Date of authorisation: 29/01/2010, Revision: 20, Status: Authorised
PSUSA/00010269/202407
Submitted by Anonymous (not verified) on 6 May 2025 - 16:30
PSUSA/00010269/202407